Insider · CIK 0001737436
Kathryn J Collier
director
Files at RGLS (Regulus Therapeutics Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Common Stock | -75,565 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -60,000 | - | - | 0 | Jun 27, 2025 |
| Jun 16, 2025 | RGLS Regulus Therapeutics Inc. | MOption exercise Common Stock | +1,396 | $9.90 | $14k | 67,844 | Jun 18, 2025 |
| Jun 17, 2025 | RGLS Regulus Therapeutics Inc. | MOption exercise Common Stock | +2,604 | $9.90 | $26k | 65,240 | Jun 18, 2025 |
| Jun 17, 2025 | RGLS Regulus Therapeutics Inc. | MOption exercise Common Stock | +2,325 | $8.80 | $20k | 62,915 | Jun 18, 2025 |
| Jun 16, 2025 | RGLS Regulus Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative | -1,396 | $0.00 | $0 | 2,604 | Jun 18, 2025 |
| Jun 17, 2025 | RGLS Regulus Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative | -2,604 | $0.00 | $0 | 0 | Jun 18, 2025 |
| Jun 17, 2025 | RGLS Regulus Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative | -2,325 | $0.00 | $0 | 0 | Jun 18, 2025 |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | AGrant or award Common Stock | +62,500 | $0.00 | $0 | 69,240 | Apr 30, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.